# Intravenous ACP-501 for Familial LCAT Deficiency (rhLCAT)

> **NCT04737720** · — · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 1 (actual)

## Conditions studied

- Familial LCAT Deficiency

## Interventions

- **DRUG:** Recombinant LCAT

## Key facts

- **NCT ID:** NCT04737720
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01-24
- **Primary completion:** 2013-12-12
- **Final completion:** —
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2026-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04737720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04737720, "Intravenous ACP-501 for Familial LCAT Deficiency (rhLCAT)". Retrieved via AI Analytics 2026-05-20 from https://api.ai-analytics.org/clinical/NCT04737720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*